Long‐term prevention of erosive or ulcerative gastro‐oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5‐year study in the United States

Antonio Caos, Jeffrey R. Breiter, Carlos Perdomo, Jay Barth

Alimentary Pharmacology & Therapeutics · 2005 · 54 citations · 14 references

DOIFull text

Open access

Abstract

Five-year maintenance therapy with rabeprazole is effective in preventing relapse of erosive or ulcerative GERD and is well tolerated.

References

14